1 Min Read
Jan 30 (Reuters) - Amgen Inc:
* AMGEN RECEIVES CHMP POSITIVE OPINION TO ADD UPDATED OVERALL SURVIVAL DATA TO KYPROLIS® (CARFILZOMIB) LABEL Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.